WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Broadens Healthcare Access: Foreign Doctors and Drug Import Reforms in N... On April 21, China's State Council unveiled a comprehensive plan to further open its service sector, with a significant focus on healthcare reforms. The ini...
(4/22/2025)

Cheaper Chinese HPV Vaccines Turn Merck's Gard... (4/23/2025)

China Broadens Healthcare Access: Foreign Doct... (4/22/2025)

As US Decouples, China Strengthens Biotech Tie... (4/22/2025)

Chinese drugmakers weigh options as US mulls p... (4/18/2025)

Interpretation of the Anti-Monopoly Guidelines... (4/17/2025)

This Pharma Company Is Betting Big On A Chines... (4/17/2025)

Off-Label Drug Use in China After the Physicia... (4/15/2025)

China's Online Pharmacy Market Surpasses CNY 7... (4/14/2025)

Trump vs China Biotech: Who Will Emerge Victor... (4/14/2025)

NIH Ban Disrupts Some Chinese Genetics Researc... (4/8/2025)

Analysis of China-to-West Pharmaceutical Licen... (4/5/2025)

China Biopharma Financing Tracker, Q1 2025 (MC... (4/5/2025)

Global Pharma Feels 'Sense of Urgency' t... (4/23/2025) China Accelerates Development of Multiva... (4/23/2025) Carbogen Amcis Secures Chinese Drug Manu... (4/22/2025) Fujifilm Capitalizes on U.S.-China Tensi... (4/22/2025) Fosun Boosts Stake in Henlius After Fail... (4/22/2025) China Seeks Feedback on ICH Draft Guidel... (4/22/2025) AZ's Ultomiris for Generalized Myastheni... (4/22/2025) China Approves New Indication of Opdivo ... (4/22/2025) Kelun-Biotech's ADC SKB518 Wins U.S. FDA... (4/22/2025) Ensem Thera Advances China-Linked Oncolo... (4/22/2025) Zai Lab's Repotrectinib sNDA Accepted by... (4/22/2025) CDE Issues the List of Reference Formula... (4/22/2025) Hengrui Initiates Phase I Trial for Nove... (4/22/2025) GemPharmatech Establishes San Diego Faci... (4/22/2025) VelaVigo Announces Second Out-Licensing ... (4/22/2025) Sanofi and Cathay Capital Launch $275M F... (4/22/2025) China Issues New Guidelines to Streamlin... (4/19/2025) Haleon Achieves Full Ownership of Tianji... (4/19/2025)

China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-... China's Retail Pharmacy Market Reaches CNY 574 Billion ... China's Pharmaceutical Market Shrinks in 2024 Amid Stru...

China Accelerates Development of Multivalent Vaccines a... Global Pharma Feels 'Sense of Urgency' to De-Risk from ... Sanofi and Cathay Capital Launch $275M Fund to Boost Ch... VelaVigo Announces Second Out-Licensing Deal for a FIC ... GemPharmatech Establishes San Diego Facility Amid U.S. ...

CDE Issues the List of Reference Formulations for GQCE ... China Seeks Feedback on ICH Draft Guideline M13B for Bi... China Issues New Guidelines to Streamline Mainland Regi... China Revises Military Drug Administration Measures to ... CDE Solicits Comments on Draft Q&A for CMC Issues in r...

NHC Ministers Meet with Top Pharma MNC Executives Beijing Unveils Ambitious Policy Package to Supercharge... China's BMI Fund Surpasses CNY16.5 Trillion with 11% An... Growing Awareness and Expanding Treatment Options for S... China Sets Ambitious Nutritional Targets for 2030 to Im...

Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t... Bayer Initiates Patent Infringement Lawsuit Against Hen... Oxford Nanopore Sues Chinese Biotech Giant BGI Over All... Congress Debates Biosecure Act Amid Report Highlighting...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

Hengrui Initiates Phase I Trial for Novel Obesity siRNA... Zai Lab's Repotrectinib sNDA Accepted by China NMPA Ensem Thera Advances China-Linked Oncology Program with... Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance China Approves New Indication of Opdivo for NSCLC

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...